About Atezolizumab
            
            Class: | Monoclonal antibody (PD-L1 inhibitor)  
Use: | Treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and small cell lung cancer (SCLC)  
Adult dose: | 1200 mg IV every 3 weeks or 840 mg IV every 2 weeks, depending on the indication  
Pediatric dose: | Safety and efficacy not established in pediatric patients; not recommended for use in children  
Side effects: | Fatigue, nausea, decreased appetite, dia
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (PD-L1 inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of locally advanced or metastatic urothelial carcinoma, non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC), and small cell lung cancer (SCLC)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: F. Hoffmann-La Roche Ltd [Basel;Switzerland], Switzerland
                    
                    
                    Package Size
                    1 Glass Vial (15mL)
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 23685.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1200 mg IV every 3 weeks or 840 mg IV every 2 weeks, depending on the indication
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children
                    
                 
                
                
                    
                        Side Effects
                    
                    Fatigue, nausea, decreased appetite, diarrhea, cough, rash, and immune-mediated adverse reactions (e.g., pneumonitis, hepatitis, endocrinopathies)
                 
             
         
        
        
            
                Contraindications & Precautions
            
            History of severe hypersensitivity reactions to Atezolizumab or any component of the formulation; active autoimmune disease requiring systemic treatment
         
        
        
            
                Important Warnings
            
            Risk of immune-mediated adverse reactions; monitor for signs and symptoms; may require corticosteroid treatment; infusion-related reactions may occur; pregnancy and breastfeeding considerations should be discussed with healthcare provider
         
        
        
        
        
        
        
        
            
                Related Medicines in Same Category
            
            
                See also: Other Monoclonal antibody (PD-L1 inhibitor) medicines available in UAE pharmacies
            
            
            
                Avelumab
            
            
            
                Durvalumab
            
            
            
                Durvalumab
            
            
         
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.